{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:14:24Z","timestamp":1778116464844,"version":"3.51.4"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,27]]},"DOI":"10.7759\/cureus.12325","type":"journal-article","created":{"date-parts":[[2020,12,27]],"date-time":"2020-12-27T19:24:46Z","timestamp":1609097086000},"source":"Crossref","is-referenced-by-count":6,"title":["Adverse Side Effects: Empagliflozin-Related Acute Pancreatitis Case Report"],"prefix":"10.7759","author":[{"given":"Bassem S","family":"Zeidan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Boadu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnathan","family":"Frunzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itioye","family":"Adetula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0901-y","article-title":"The potential role of SGLT2 inhibitors in the treatment of type 1 diabetes mellitus","volume":"78","author":"Fattah H","year":"2018","unstructured":"Fattah H, Vallon V. The potential role of SGLT2 inhibitors in the treatment of type 1 diabetes mellitus. Drugs. 2018, 78:717-726. 10.1007\/s40265-018-0901-y","journal-title":"Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000311","article-title":"An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus","volume":"24","author":"Hsia DS","year":"2017","unstructured":"Hsia DS, Grove O, Cefalu WT. An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 2017, 24:73-79. 10.1097\/MED.0000000000000311","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref3","article-title":"Empagliflozin in the treatment of type 2 diabetes: evidence to date","volume":"9","author":"Shubrook JH","year":"2015","unstructured":"Shubrook JH, Bokaie BB, Adkins SE. Empagliflozin in the treatment of type 2 diabetes: evidence to date. Drug Design Dev Therapy. 2015, 9:5793-5803.","journal-title":"Drug Design Dev Therapy"},{"key":"ref4","article-title":"Acute pancreatitis","volume":"2","author":"Fan BG","year":"2010","unstructured":"Fan BG, Andr\u00e9n-Sandberg A. Acute pancreatitis. N Am J Med Sci. 2010, 2:211-214.","journal-title":"N Am J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.4.565","article-title":"Drug induced acute pancreatitis: incidence and severity","volume":"37","author":"Lankisch PG","year":"1995","unstructured":"Lankisch PG, Dr\u00f6ge M, Gottesleben F. Drug induced acute pancreatitis: incidence and severity. Gut. 1995, 37:565-567. 10.1136\/gut.37.4.565","journal-title":"Gut"},{"key":"ref6","article-title":"Drug-induced acute pancreatitis: a review","volume":"15","author":"Jones MR","year":"2015","unstructured":"Jones MR, Hall OM, Kaye AM, Kaye AD. Drug-induced acute pancreatitis: a review. Ochsner J. 2015, 15:45-51.","journal-title":"Ochsner J"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201710001-01306","article-title":"Consideration for empagliflozin-associated pancreatitis","volume":"112","author":"Lightbourne T","year":"2017","unstructured":"Lightbourne T, Najafian N, McCarty T. Consideration for empagliflozin-associated pancreatitis. Am J Gastoenterol. 2017, 112:S710.","journal-title":"Am J Gastoenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/28412-adverse-side-effects-empagliflozin-related-acute-pancreatitis-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:29Z","timestamp":1707506729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/28412-adverse-side-effects-empagliflozin-related-acute-pancreatitis-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,27]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.12325","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,27]]}}}